Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 0.804\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) O=C1CCCc2c1nc(-c1ccc(F)cc1)n2O
(b) O=C(NCCNc1ccc([N+](=O)[O-])cc1)c1cccs1
(c) Clc1ccc(C2CC(c3ccco3)n3ncnc3N2)cc1Cl
(d) COc1ccc(/C=N/OC(=O)Nc2ccc(Cl)cc2)c(OC)c1
Answer: c. Clc1ccc(C2CC(c3ccco3)n3ncnc3N2)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(C2CC(c3ccco3)n3ncnc3N2)cc1Cl
Clc1ccc(C2CC(c3ccco3)n3ncnc3N2)cc1Cl
5-(3,4-dichlorophenyl)-7-(furan-2-yl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidine